Wakefit Innovations Allots 31.38 Lakh Equity Shares Under Employee Stock Option Plan 2019
Wakefit Innovations Limited allotted 31,38,074 equity shares under ESOP 2019 on March 18, 2026, increasing paid-up capital to ₹32,99,66,749. The shares were issued at ₹1 face value to eligible employees exercising vested stock options, with no lock-in period or premium charges. The company confirmed regulatory compliance and emphasized the allotment's non-material nature.
*this image is generated using AI for illustrative purposes only.
Wakefit Innovations Limited has announced the successful allotment of 31,38,074 equity shares under its Employee Stock Option Plan 2019 (ESOP 2019) on March 18, 2026. The Board of Directors approved this allotment through a resolution passed on the same date, enabling eligible employees to exercise their vested stock options.
Share Allotment Details
The allotted equity shares carry a face value of ₹1 each and are fully paid-up. These shares were issued in dematerialized form to eligible employees and ESOP holders who exercised their stock options under the WAKEFIT ESOP-2019 scheme. The exercise price for each share was set at ₹1 with no premium charged.
Impact on Share Capital Structure
The allotment has resulted in a significant increase in the company's equity base:
| Parameter | Pre-allotment | Post-allotment |
|---|---|---|
| Number of Equity Shares | 32,68,28,675 | 32,99,66,749 |
| Face Value | ₹1 | ₹1 |
| Paid-up Equity Capital | ₹32,68,28,675 | ₹32,99,66,749 |
The newly issued shares carry distinctive numbers ranging from 32,68,28,676 to 32,99,66,749 and are identical in all respects to the existing equity shares of the company.
Regulatory Compliance and Disclosures
Wakefit Innovations has filed the necessary documentation with both BSE Limited and National Stock Exchange of India Limited, where the company's shares are listed. The filing was made on January 19, 2026, with reference numbers BSE: DCS/ESOP/IP/NB/4087/2025-26 and NSE: NSE/LIST/53076 for in-principle approval.
The company has emphasized that this share allotment is not material in nature and complies with:
- Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
- Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Key Transaction Features
The ESOP allotment includes several notable aspects:
- No Lock-in Period: The allotted shares are not subject to any lock-in restrictions
- Dematerialized Form: All shares were issued in electronic format with ISIN number INE0E7301029
- No Listing Fees: No additional listing fees are applicable for this allotment
- Employee Benefit: The allotment represents the exercise of vested options by eligible employees under the 2019 scheme
The company has made all relevant information available on its investor relations website and has notified both stock exchanges as per regulatory requirements. This ESOP exercise demonstrates Wakefit's commitment to employee participation in the company's equity growth.
Historical Stock Returns for Wakefit Innovations
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.84% | -6.31% | -18.64% | -20.95% | -20.95% | -20.95% |
How might this ESOP exercise impact Wakefit's employee retention and talent acquisition strategy in the competitive sleep and furniture market?
What does the timing of this large ESOP allotment suggest about Wakefit's potential IPO plans or future fundraising activities?
Could this dilution of approximately 0.96% affect Wakefit's valuation metrics and attractiveness to institutional investors?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
